Cite
MLA Citation
Xenofon Baraliakos et al.. “Real‐world evidence for subcutaneous infliximab (CT‐P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID‐19) pandemic: A case series.” Clinical case reports, vol. 10, no. 1, 2022, p. n/a. http://access.bl.uk/ark:/81055/vdc_100150584195.0x000011